Improve Physique & Muscles - MyoBlox Contra
If you're looking for a new & improved Muscle builder, MyoBlox has got you covered. MyoBlox Contra will help to support strength gains, promote a ripped physique, & help build Muscle overall. MyoBlox Contra will help to suppress Cortisol levels, & come in easy, on-the-go capsules. Get swole & pick up a bottle today. Introducing MyoBlox Contra!!
MyoBlox Contra Muscle Builder Benefits
- Supports Strength Gains
- Promotes A Ripped Physique
- Easy, On-The-Go Capsules
- Helps To Suppress Cortisol
- Helps To Build Muscle
How Do I Take MyoBlox Contra Muscle Builder?
As a dietary supplement, begin by taking 1 dose (1 capsule) in the morning with your first meal. Wait approximately 8-12 hours , consume a second dose (1 capsule) with a meal. Due to formula potency, do not use this product longer than 8 weeks followed by a 4 week break. Do not exceed 2 capsules in any 24 hour period. Contra is meant to be taken for up to 8 weeks before cycling off.
MyoBlox Contra Muscle Builder Ingredients
Serving Size: 2 Capsules
Servings Per Container: 28
Contra (2 Capsules) 1150mg
Anti-Cortisol Matrix 600mg: KSM-66 Ashwagandha Root Extract (Standardized To >5% Withanolides)
Pro-Physique Matrix 540mg: 3,3'-Diindolymethane, Androsta-3,5, Diene-7,17-Dione, N-Cuomaroyldopamine, BLOX Micro Peptide Technology (Yielding Natural Occurring Fibroblast Growth Factors, Folistatin)
Absorption Matrix 10mg: Piperine Alkaloids (98%)
Other Ingredients: Silicon Dioxide, Rice Flour, Gelatin.
MyoBlox Contra Muscle Builder Side Effects & Warnings
Do not consume more than 2 capsules in a 24 hour period. Store in a cool, dry place.
Choudhary B, Shetty A, Langade DG. Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults. Ayu. 2015;36(1):63‐68. doi:10.4103/0974-8520.169002
Salve J, Pate S, Debnath K, Langade D. Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. Cureus. 2019;11(12):e6466. Published 2019 Dec 25. doi:10.7759/cureus.6466